MediWound Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Initiated VALUE, a global Phase III pivotal trial of EscharEx® for venous leg ulcersExpanded strategic research collaborations with industry ...
MediWound Ltd.: MediWound Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Initiated VALUE, a global Phase III pivotal trial of EscharEx® for venous leg ulcers Expanded strategic research collaborations with industry leaders, now including Kerecis $20 million in revenue for ...
Gaucho Group Holdings, Inc. Announces Settlement Term Sheet and Plan for Structured Exit from Chapter 11
Agreement Provides for Structured Settlement and Dismissal of Litigation MIAMI, FL / ACCESS Newswire / March 18, 2025 / Gaucho Group Holdings, ...